Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04118257 · ClinicalTrials.gov registry record · NA

Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors

A NA study of Metabolic Syndrome, sponsored by Kansas State University.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT04118257 is a NA study of Metabolic Syndrome that has completed, run by Kansas State University. The registered enrollment target is 37 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04118257, a NA study of Metabolic Syndrome, has completed, sponsored by Kansas State University.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

Our goal is to determine how the addition of sugar-sweetened beverages to the diet affects glucose control, cardiovascular disease risk factors, and pulmonary function in healthy, young adults.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Control: Water
  • DIETARY_SUPPLEMENT Sugary beverage: Fruit juice
  • DIETARY_SUPPLEMENT Sugary beverage: Soda

Study Locations (1)

Kansas

  • Lafene Health Center - Manhattan

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2017-02-10
Est. Completion 2018-11-14
Phase NA

Sponsor

Kansas State University

22 total trials

What the Registry Record Tells You About NCT04118257

The ClinicalTrials.gov registry entry for NCT04118257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (97% lower). The listed sponsor is Kansas State University, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Metabolic Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Control: Water is the first listed.

NCT04118257 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT04118257 about?

NCT04118257 is a clinical study titled "Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors". Our goal is to determine how the addition of sugar-sweetened beverages to the diet affects glucose control, cardiovascular disease risk factors, and pulmonary function in healthy, young adults.

What is the current status of trial NCT04118257?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-02-10. Estimated completion is 2018-11-14.

What conditions does trial NCT04118257 study?

This clinical trial studies the following conditions: Metabolic Syndrome.

What interventions are being tested in trial NCT04118257?

The interventions under investigation include: Control: Water (DIETARY_SUPPLEMENT), Sugary beverage: Fruit juice (DIETARY_SUPPLEMENT), Sugary beverage: Soda (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04118257?

This trial is sponsored by Kansas State University, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04118257 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.